SOLAI Limited Faces NYSE Delisting Notice After ADSs Fall Below US$1; Adds New Director
SOLAI Limited received a NYSE notice on January 29, 2026 after its ADSs averaged below US$1.00 over 30 consecutive trading days, triggering a six-month cure period before potential delisting proceedings. It replaced longtime director Qian Sun with entrepreneur Zhan Chen on audit, nominating and strategy committees to strengthen governance.
1. NYSE Continued Listing Notice
On January 29, 2026, SOLAI received a continued listing notice from the New York Stock Exchange because its ADSs averaged below US$1.00 over a consecutive 30 trading-day period. The company has six months to restore a closing price and 30-day average at or above US$1.00 on the last trading day of any month to avoid suspension and delisting procedures.
2. Board Changes and Governance
Independent director Qian Sun resigned effective immediately for personal reasons without any board disagreement. SOLAI appointed Zhan Chen as his successor, assigning him to the audit, nominating and corporate governance, and strategy committees; Chen brings entrepreneurial leadership from roles at Open Mouth Food Inc., Boba Labs Inc. and other fintech and technology ventures.